140 related articles for article (PubMed ID: 33837882)
21. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
Li J; Zou X
Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
[TBL] [Abstract][Full Text] [Related]
22. miR-522 regulates cell proliferation, migration, invasion capacities and acts as a potential biomarker to predict prognosis in triple-negative breast cancer.
Wang W; Zhang W; Wu J; Zhou Z; Ma J
Clin Exp Med; 2022 Aug; 22(3):385-392. PubMed ID: 34518949
[TBL] [Abstract][Full Text] [Related]
23. miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer.
Zhang W; Sun Z; Su L; Wang F; Jiang Y; Yu D; Zhang F; Sun Z; Liang W
Eur J Pharmacol; 2018 Apr; 825():75-84. PubMed ID: 29454608
[TBL] [Abstract][Full Text] [Related]
24. The roles of miR-200c in colon cancer and associated molecular mechanisms.
Chen J; Wang W; Zhang Y; Hu T; Chen Y
Tumour Biol; 2014 Jul; 35(7):6475-83. PubMed ID: 24682933
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Huang Y; Xiao W; Jiang X; Li H
Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).
Tong F; Ying Y; Pan H; Zhao W; Li H; Zhan X
Bosn J Basic Med Sci; 2018 Aug; 18(3):252-259. PubMed ID: 29338680
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of miR-1269 Contributes to the Progression of Esophageal Squamous Cell Cancer Cells and Is Associated With Poor Prognosis.
Bai X; Wang Q; Rui X; Li X; Wang X
Technol Cancer Res Treat; 2021; 20():1533033820985858. PubMed ID: 33416035
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer.
Wang R; Li G; Zhuang G; Sun S; Song Z
Diagn Pathol; 2019 Jun; 14(1):53. PubMed ID: 31164163
[TBL] [Abstract][Full Text] [Related]
29. miR-1231 Is Downregulated in Prostate Cancer with Prognostic and Functional Implications.
Wang Y; Zhang Q; Guo B; Feng J; Zhao D
Oncol Res Treat; 2020; 43(3):78-86. PubMed ID: 31822000
[TBL] [Abstract][Full Text] [Related]
30. Down-regulated expression of miR-582 predicts poor prognosis and facilitates melanoma progression by targeting FOXC1.
Chen F; Zhang D
Arch Dermatol Res; 2022 Oct; 314(8):759-766. PubMed ID: 34628519
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of miR-421 predicts poor prognosis and promotes proliferation, migration, and invasion of papillary thyroid cancer cells.
Dong A; Zhang J; Sun W; Hua H; Sun Y
J Chin Med Assoc; 2020 Nov; 83(11):991-996. PubMed ID: 32881717
[TBL] [Abstract][Full Text] [Related]
32. High miR-324-5p expression predicts unfavorable prognosis of gastric cancer and facilitates tumor progression in tumor cells.
Zheng Z; Li J; An J; Feng Y; Wang L
Diagn Pathol; 2021 Jan; 16(1):5. PubMed ID: 33430926
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of miR-671-5p indicates a poor prognosis in colon cancer and accelerates proliferation, migration, and invasion of colon cancer cells.
Jin W; Shi J; Liu M
Onco Targets Ther; 2019; 12():6865-6873. PubMed ID: 31686843
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
[TBL] [Abstract][Full Text] [Related]
35. MiR-519a functions as a tumor suppressor and is negatively associated with poor prognosis of non-small cell lung cancer.
Wang Y; Jiang F; Wang J; Fu Y; Li Y; Li F
Cancer Biomark; 2020; 28(1):121-128. PubMed ID: 32224524
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of miR-331 Indicates Poor Prognosis and Promotes Progression of Breast Cancer.
Jiang F; Zhang L; Liu Y; Zhou Y; Wang H
Oncol Res Treat; 2020; 43(9):441-448. PubMed ID: 32818938
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
[TBL] [Abstract][Full Text] [Related]
38. MiR-195 suppresses colon cancer proliferation and metastasis by targeting WNT3A.
Li B; Wang S; Wang S
Mol Genet Genomics; 2018 Oct; 293(5):1245-1253. PubMed ID: 29948330
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of miR-140 is Correlated with Poor Prognosis and Progression of Thyroid Cancer.
Yu Q; Sun W; Hua H; Chi Y; Liu X; Dong A; Sun Y; Zhang J; Guan G
Endocr Metab Immune Disord Drug Targets; 2021; 21(4):749-755. PubMed ID: 32713344
[TBL] [Abstract][Full Text] [Related]
40. circRNA_100859 functions as an oncogene in colon cancer by sponging the miR-217-HIF-1α pathway.
Zhou P; Xie W; Huang HL; Huang RQ; Tian C; Zhu HB; Dai YH; Li ZY
Aging (Albany NY); 2020 Jul; 12(13):13338-13353. PubMed ID: 32644049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
